Zegerid OTC | Zegerid OTC
|Active ingredients (in each capsule)||Purpose|
|Omeprazole 20 mg||Acid reducer|
|Sodium Bicarbonate 1100 mg||Allows absorption of this omeprazole product|
Do not use if you are allergic to omeprazole
Do not use if you have:
These may be the signs of a serious condition. See your doctor.
Ask a doctor or pharmacist before use if you are taking
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Heartburn in children may sometimes be caused by a serious condition.
croscarmellose sodium, FD&C blue No. 1, gelatin, magnesium stearate, pharmaceutical ink, polysorbate 80, titanium dioxide
Call 1-888-ZEG-OTC (1-888-493-4682) between 8:00AM and 5:00PM Central Standard Time, Monday through Friday or visit www.ZegeridOTC.com
© Copyright & Distributed by MSD Consumer Care, Inc., PO Box 377, Memphis, TN 38151 USA, a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ USA.
Treats Frequent Heartburn
Three 14-Day Courses of Treatment
MSD Consumer Care, Inc.
Drugs and Medications
These highlights do not include all the information needed to use ZEGERID safely and effectively. See full prescribing information for ZEGERID. ZEGERID (omeprazole/sodium bicarbonate) Powder for Oral...
ZEGERID® with Magnesium Hydroxide (omeprazole/sodium bicarbonate/magnesium hydroxide)
Compare the percent of subjects with moderate/severe esophagitis who achieve complete endoscopic resolution after 8 weeks of treatment morning vs. bedtime.
The purpose of this study is to compare Prilosec OTC® and Zegerid® in their effects on gastric acid suppression.
This research is to determine which medication, Zegerid (Omeprazole/Sodium Bicarbonate) or Pepcid AC (Famotidine), works best at reducing the chance that a patient will get an ulcer after...
This study will determine differences between PPI formulations relative to their effects on gastric acidity
Open-label randomized crossover design study. 60 participants will be evaluated on Day 1 to compare effects on stomach acid; 30 participants will continue treatment for 7 days and will hav...